Renuvion
Dermal Resurfacing for Wrinkles & Rhytids
Key Facts
About Apyx Medical
Apyx Medical is a publicly traded medical technology company focused on developing and commercializing advanced energy systems for surgical and aesthetic procedures. Its primary achievement is the Renuvion platform, which utilizes helium plasma technology for controlled tissue effects. The company's strategy involves expanding the clinical indications for Renuvion, launching its next-generation AYON system, and leveraging its OEM segment for manufacturing revenue. Apyx aims to establish its technology as a standard of care in targeted surgical markets.
View full company profileAbout Apyx Medical
Apyx Medical is a publicly traded medical technology company focused on developing and commercializing advanced energy systems for surgical and aesthetic procedures. Its primary achievement is the Renuvion platform, which utilizes helium plasma technology for controlled tissue effects. The company's strategy involves expanding the clinical indications for Renuvion, launching its next-generation AYON system, and leveraging its OEM segment for manufacturing revenue. Apyx aims to establish its technology as a standard of care in targeted surgical markets.
View full company profileAbout Apyx Medical
Apyx Medical is a publicly traded medical technology company focused on developing and commercializing advanced energy systems for surgical and aesthetic procedures. Its primary achievement is the Renuvion platform, which utilizes helium plasma technology for controlled tissue effects. The company's strategy involves expanding the clinical indications for Renuvion, launching its next-generation AYON system, and leveraging its OEM segment for manufacturing revenue. Apyx aims to establish its technology as a standard of care in targeted surgical markets.
View full company profileAbout Apyx Medical
Apyx Medical is a publicly traded medical technology company focused on developing and commercializing advanced energy systems for surgical and aesthetic procedures. Its primary achievement is the Renuvion platform, which utilizes helium plasma technology for controlled tissue effects. The company's strategy involves expanding the clinical indications for Renuvion, launching its next-generation AYON system, and leveraging its OEM segment for manufacturing revenue. Apyx aims to establish its technology as a standard of care in targeted surgical markets.
View full company profile